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The marine biotoxin domoic acid (DA),
produced by the cosmopolitan diatom genus
Pseudo-nitzschia, is responsible for causing
amnesic shellfish poisoning (ASP). DA can
affect many different species, most often by the
contamination of shellﬁsh beds and planktivo-
rous fish via filter feeding. Subsequent con-
sumption by other organisms can lead to
accumulation of DA in higher trophic levels,
including avian, marine mammal, and human
populations (Gulland et al. 2002; Lefebvre
et al. 1999; Scholin et al. 2000; Work et al.
1993). The consequent effects of DA exposure
in these organisms are multiple, with previous
research focusing on the behavioral and neuro-
logical effects of exposure.
Symptomatic responses to DA exposure
have been documented in mice, rats, and
cynomolgus monkeys (Iverson et al. 1989;
Tasker et al. 1991; Tryphonas et al. 1990a,
1990b) with the most common behavioral
symptoms being scratching, tremors, and
seizures at varying doses of DA. These
responses also parallel those observed from
environmental exposures in sea lions (Gulland
et al. 2002). Various researchers have also
reported that DA exposure causes prolonged
neuroexcitation and extensive degeneration
in the hippocampus as well as more rostral
areas of the brain, including the septum and
olfactory bulb (Peng and Ramsdell 1996;
Peng et al. 1994; Scallet et al. 1993, 2004).
DA-induced damage to hippocampal forma-
tion has been correlated with both learning
(Clayton et al. 1999) and memory deﬁcits in
humans and experimental animals (Nakajima
and Potvin 1992; Petrie et al. 1992; Sutherland
et al. 1990; Teitelbaum et al. 1990).
Most of these previous experiments have
dealt with mature subjects, leaving the impact
of DA exposure on fetal development rela-
tively poorly understood and studied.
Dakshinamurti et al. (1993) demonstrated
that intrauterine exposure of DA indicated
age-related developmental neurotoxicity in
mice, with hippocampal necrosis observable
after 30 days of age. Xi et al. (1997) reported
that neonatal rats were substantially more sus-
ceptible to DA exposure than adults. Because
these animals maintained higher blood levels
of DA, Xi et al. (1997) proposed that suscep-
tibility resulted from insufﬁcient renal clear-
ance of toxin. The susceptibility diminished
as a function of neonatal age (Doucette et al.
2000; Xi et al. 1997), corresponding to the
maturation of renal function.
The rapidity with which DA clears from
an exposed organism’s blood (> 99% in 4 hr)
(Suzuki and Hierlihy 1993; Truelove and
Iverson 1994) is also a factor when assessing
DA exposure. This fast clearance makes it dif-
ficult to detect DA after exposure within a
suitable time frame, especially when consid-
ered from a biomonitoring stance. The preva-
lence of this marine biotoxin and its effects
on marine mammal and human populations
makes biomonitoring capability an important
consideration, especially understanding the
impact of maternal exposure and the sub-
sequent effects on neonates as a susceptible
population.
Because it is known that DA is neurotoxic
and can affect neonatal more readily than adult
rats (Xi et al. 1997), our study focused on
whether DA could be transferred from DA-
exposed rat mothers (dams) to the young
through milk. The presence of DA was meas-
ured using an antibody-based approach
(Garthwaite et al. 1998) via direct competitive
enzyme-linked immunosorbant assay (cELISA)
with a limit of detection < 0.01 ng/mL. The
cELISA has been used successfully to detect
low DA concentrations in blood extracts and
plasma from laboratory exposures (Maucher
and Ramsdell, in press). Additionally, we
explored the partitioning of DA in milk,
plasma, and urine of exposed dams, and the
clearance of DA from each matrix.
Materials and Methods
Rat exposure: dams. All animal exposures were
performed by Argus Research (Horsham, PA),
a division of Charles River Laboratories, Inc.
Twelve female Crl:CD(SD)IGS BR VAF/Plus
rats, 318–418 g, and their respective litters,
were provided by Charles River Laboratories,
Inc. (Horsham, PA), and dams were divided
into three treatment groups. Groups 1 and 2
were injected intraperitoneally (ip) with a non-
lethal dose of 1.0 mg/kg (0.1 mg/mL) DA
(Sigma, St. Louis, MO) in phosphate-buffered
saline (PBS) on day 12 of lactation. Group 3
control mice were injected with an equal vol-
ume of PBS. This dose was chosen because the
threshold for neurological symptoms in adult
rats is between 1.0 and 2.0 mg/kg (Tryphonas
et al. 1990b). Blood was collected from the
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Domoic acid (DA), produced by the diatom genus Pseudo-nitzschia, is a glutamate analog and a
neurotoxin in humans. During diatom blooms, DA can contaminate ﬁlter-feeding organisms, such
as shellﬁsh, and can be transferred by ingestion to higher trophic levels. Several intoxication events
involving both humans and various marine mammals have been attributed to DA. Affected organ-
isms show neurological symptoms such as seizures, ataxia, headweaving, and stereotypic scratch-
ing, as well as prolonged deﬁcits in memory and learning. Neonatal animals have been shown to
be substantially more sensitive to DA than adults. However, it has not been demonstrated whether
DA can be transferred to nursing young from DA-exposed mothers. This study demonstrates
transfer of DA from spiked milk (0.3 and 1.0 mg/kg) to the plasma of nursing neonatal rats and
an overall longer DA retention in milk than in plasma after 8 hr in exposed dams. DA
was detectable in milk up to 24 hr after exposure (1.0 mg/kg) of the mothers, although the
amount of DA transferred to milk after exposure was not sufﬁcient to cause acute symptoms in
neonates. Key words: amnesic shellfish poisoning, domoic acid, ELISA, milk, plasma, urine.
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[Online 20 January 2005]jugular vein 1, 4, 8, and 24 hr after exposure,
transferred into dipotassium EDTA-coated
tubes, and centrifuged. Plasma was collected
and frozen (–68 to –78°C) until shipment for
analysis. After blood collection, dams were
given one unit oxytocin to stimulate lactation
approximately 5 min before collection of milk
samples. Milk was collected from group 1
dams at 1, 8, and 24 hr after dosing, from
group 2 dams at 4 hr after dosing, and from
group 3 control dams at 24 hr after dosing.
Milk from the group 2 and group 3 collection
points was put aside for either direct or DA-
spiked feeding, respectively, to group 1 and
group 2 pups; the remaining samples
were then frozen until shipment for analysis.
Urine samples were also collected from the
dams throughout the following time intervals:
0–4 hr, 4–8 hr, and 8–24 hr after dosing from
group 1 dams and 2–24 hr after dosing from
group 3 (control) dams.
Rat exposure: pups. Postnatal day (PND)
12 pups from the dams described above
were also divided into three groups. Milk from
group 3 control dams was spiked at 0.3 and
1.0 mg/kg and given to pup groups 1 and 2,
respectively, via oral gavage. Group 3 pups were
treated via oral gavage with milk collected
at hour 4 from group 2 dams (1.0 mg/mL
exposed). Under isoflurine anesthesia, pup
blood was collected 2 hr after dosing via cardiac
puncture, centrifuged to collect plasma, and the
plasma frozen (–68 to –78°C) until shipment
for analysis. The 1.0 mg/kg dose was previously
determined by preliminary range-ﬁnding exper-
iments (1.0–8.0 mg/kg) to be at the lowest
observable effect level (LOEL) for neonatal rats
(PND10) using oral exposure. This LOEL was
based on a modified Tasker scoring system
(Tasker et al. 1991), with head tremors being
the most common behavioral response of pups
in the 1.0-mg/kg group, and a dose-dependent
increase in severity of symptoms (scratching,
whole body tremors, convulsions) with the
higher dosed pups (data not shown).
ASP direct cELISA kit. We used ASP direct
cELISA kits (Kleivdal H et al., unpublished
data) from Biosense Laboratories (Bergen,
Norway; www.biosense.com) to analyze all
plasma, urine, and milk samples. This kit uses a
polyclonal ovine anti-DA antibody (Garthwaite
et al. 1998) conjugated to horseradish peroxi-
dase (HRP), to which free DA in samples or
standards compete with DA-conjugated pro-
teins coated on the plate well surface. Samples
were incubated with the antibodies, washed
with PBS with 0.05% Tween 20 (PBST), and
then treated with tetramethylbenzidine, which
reacts with the HRP enzyme to form a blue
end-product. Addition of 0.3 M H2SO4 turned
the blue to yellow, and the plate was read on a
FluoStar plate reader (BMG Labtechnologies,
Durham, NC) at 450 nm. Analyses of DA con-
centrations in the standard curve and samples
were done using ELISA data processing soft-
ware provided by Biosense Laboratories.
Additional analyses were done using Prism 4.0
(Graphpad, San Diego, CA).
Sample dilutions. Samples were diluted
either 1:10 or 1:100 before being run on the
cELISA. Plasma samples run at 1:10 were
compared by t-test (Prism 4.0; Graphpad) to
a matrix control at the same dilution, due to
matrix effects at this low dilution, to qualita-
tively express the presence or absence of DA.
Milk samples were quantified on a standard
curve with milk matrix present at a 100-fold
dilution for each standard concentration. We
ran other standard curves in the presence of
urine and milk at 100-fold dilutions to assess
any matrix effects.
Results
Matrix effects. When the Biosense kit stan-
dard curve, run in PBST, was compared to
the same standard curve run in the presence
of plasma, urine, and milk matrices, each at
100-fold dilutions for each standard concen-
tration, resulting EC50 (half-maximal effec-
tive) values were 75.70, 65.15, 72.85, and
33.34 pg/mL, respectively (Figure 1). A 33%
decrease in the maximum absorbance value
(Amax) was observed between the standard
curve and the 1:100 milk standard curve,
indicating a matrix effect in milk, along with
the lowered EC50. The other matrices at the
same 1:100 dilution showed no such matrix
effect. A similar decrease in Amax absorbance
was also determined previously in blood
diluted 10-fold (data not shown).
Clearance of DA from blood. The exposed
dams showed a rapid clearance of DA from
plasma, with > 99% eliminated in the ﬁrst hour
(Figure 2). However, 4 ng/mL was still quan-
tiﬁable after 8 hr, and DA was still detectable at
24 hr (Figure 2) when compared to the control
rat (group 3) plasma at the same 1:10 dilution
as the treated rats (groups 1 and 2; p < 0.005).
There was a signiﬁcant difference between raw
absorbances of the control plasma extract and
the treated dams at 24 hr, with a 10-fold dilu-
tion each (p < 0.005; Figure 2). These results
indicate the ability to detect the presence of
DA in plasma 24 hr after exposure and to
quantify the amount of DA present at ≤ 8 hr
after exposure.
Clearance from milk. There was a matrix
effect evident in the 100-fold diluted milk
samples, so we analyzed the milk samples using
a standard curve in the presence of milk at the
same 100-fold dilution to accurately ascertain
the DA concentrations (data not shown). The
amount of DA present in milk decreased
rapidly, with < 1% still detectable within the
first 2 hr; however, 3 ng/mL DA were still
measurable at 24 hr (Figure 3). There was only
a 20% change in DA concentration between
the 1- and 8-hr time points, in contrast to the
> 99% change in the concentration of DA in
the plasma extracts between the same time
points (Figure 4). There was 4-fold greater DA
retained in milk than plasma at the 8-hr time
point, and 3 ng/mL DA still quantifiable at
24 hr, whereas DA was only detectable in
plasma at 24 hr (Figure 4). This indicates a
longer retention time of DA in milk than in
plasma.
Clearance from urine. The DA concentra-
tions found in urine within the ﬁrst hour after
dosing were 3 orders of magnitude higher
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Figure 1. Comparison of DA standard curves run
with PBS and in the presence of 100-fold dilutions of
plasma, milk, and urine matrices. Abs, absorbance
values. Error bars represent SDs (n = 2).
Figure 2. DA concentrations in blood of exposed
dams (1.0 mg/kg) over time (n = 6). The limit of
quantiﬁcation (LOQ) for a sample was 1.0 ng/mL.
*Indicates detectable but nonquantiﬁable DA via a statisti-
cally significant difference in mean from the control as
determined by paired t-test (p = 0.004).
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Figure 3. Concentrations of DA in milk of exposed
dams (1.0 mg/kg) at three time points. Errors bars rep-
resent SDs (n = 4), and each time point was signiﬁ-
cantly different from the control (one-way analysis of
variance with Dunnett’s post-test; p < 0.05). The limit
of quantiﬁcation (LOQ) for a sample was 1.0 ng/mL.
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< LOQthan any of the other matrices. Initial DA val-
ues were 310 µg/mL during the 0–4 hour time
period, 210 µg/mL during the 4–8 hr collec-
tion period, and decreased to approximately
6 µg/mL between 8 and 24 hr (Figure 5).
There was no detectable DA in the 2–24 hr
control.
Transfer from dam to pup. There was no
detectable DA in the plasma of pups that had
been given milk collected from group 2 dams
4 hr after exposure to 1.0 mg/kg, whereas pups
exposed to the DA-spiked milk (0.03 and 1.0
mg/kg) did have measurable amounts of DA in
plasma (Figure 6). Two hours after exposure, >
99% of DA had cleared from plasma of pups
from both the 0.03-mg/kg and the 1.0-mg/kg
groups (Figure 6).
Discussion
DA mortality events have become prevalent
in recent years, especially in marine mam-
mals, including sea lions, sea otters, and dol-
phins, off the coast of California. Although it
is known that DA is transferred to higher
trophic levels by seafood consumption, it is
not known whether DA can also be trans-
ferred from an intoxicated mother to her
young through milk. The purpose of this
research was to determine how DA is parti-
tioned in various body ﬂuids after exposure to
a sublethal dose and whether transfer of DA is
possible through milk.
Our results showed that after a 1.0-mg/kg
DA intraperitoneal exposure to lactating rats,
there was a large range in retention of DA with
time among the three body fluids tested.
Results of DA partitioning among the three
experimental body ﬂuids of the exposed dams
(plasma, urine, and milk) showed that most of
the DA is excreted through the urine, which
had initial 1-hr values 3 orders of magnitude
greater than that in plasma, which, in turn had
10 times higher DA than that found in milk.
This supports previous assertions that most sys-
temic DA is cleared quickly through the kid-
neys. Suzuki and Hierlihy (1993) determined a
clearance rate through rat kidneys of approxi-
mately 9.12 mL/min per kg body weight, and
a half-life of roughly 20 min was reported by
Truelove and Iverson (1994). Evidence for
renal clearance also came from older patients
that ingested DA-contaminated mussels in
Canada in 1987 (Perl et al. 1990), as those
with compromised kidney function were more
severely affected by the DA exposure.
With the kidneys ﬁltering much of the DA
from the blood, less DA was detectable in the
plasma of the exposed dams. More than 99%
was cleared within 4 hr, which is similar to pre-
vious results by Peng and Ramsdell (1996) and
Maucher and Ramsdell (in press). Hence, the
clearance of DA from plasma is rapid, which
would ordinarily make biomonitoring the
plasma of exposed organisms difﬁcult were it
not for the sensitive detection method used.
The cELISA enabled us to measure plasma
concentrations of DA 8 hr after exposure,
based on the EC20 value of the Biosense soft-
ware used for analysis, and also to detect but
not quantify DA present at 24 hr by compari-
son to a control.
The results of DA retention in milk were
interesting for two reasons. First, although the
DA concentrations in milk were 16 times lower
than that in plasma at the 1-hr time point, by
8 hr (i.e., milk collected between the 1-hr and
8-hr interval) there was a four-fold higher quan-
tity remaining in the milk compared to the
plasma. Second, using the cELISA, there was
still a quantiﬁable concentration of DA in milk
collected in the 8–24 hr interval, whereas at the
same time point in plasma, DA was detectable
but not measurable. Because DA is retained
longer in milk than in plasma, milk should be a
useful ﬂuid for biomonitoring DA exposure in
lactating animals and humans. These results
also initially suggested to us that, even in light
of the rapid clearance, DA could potentially be
transferred to feeding neonates and thus put
them at higher risk for abnormal development,
although our additional data failed to support
this hypothesis.
Neonates exposed to DA-spiked milk
absorbed the toxin, and the DA was measur-
able in their plasma. The amount of toxin
spiked into the milk (1.0 mg/kg) was deter-
mined by preliminary range-finding experi-
ments to be at the LOEL for neonatal rats
using oral exposure (data not shown). This
dose, and the lower dose of 0.3 mg/kg, led
to measurable levels of plasma DA in the
neonates at 2 hr. However, in this experiment,
there was no detectable DA in the plasma of
the neonates administered milk collected from
dams exposed to 1.0 mg/kg DA 4 hr earlier.
The amount of DA that accumulated in the
milk over this first 4-hr collection period
(60 ng/mL) would yield an oral dose of
240 ng/kg for a single 0.1-mL oral administra-
tion. Therefore, this oral dosage yields plasma
levels in the neonate well below the limit of
detection for DA.
We initially wanted to know if lactation
was a relevant route of exposure for DA toxic-
ity to neonates for several reasons. DA has
potent developmental and neurological effects
during early life stages. Neonatal rats have
been shown to be up to 40 times more suscep-
tible to DA exposure than adults (Xi et al.
1997), most likely due to underdeveloped
renal ﬁltration of the toxin. Incomplete devel-
opment of the blood–brain barrier in neonates
may also render them more susceptible to the
effects of DA than adults (Preston and Hynie
1991). Doucette et al. (2003) showed that even
low doses of DA (20 µg/kg) between PND8
and PND14 caused neurobehavioral changes
such as early eye opening and decreased activity
levels. Wang et al. (1999) showed that sub-
cutaneous DA doses of 0.33 mg/kg, similar to
our lowest dose by gavage, given to PND7
rats were enough to induce hindlimb paraly-
sis, tremors, and death. A decrease of DA
toxicity with increasing age of neonatal rats
has also been determined by Xi et al. (1997)
and Doucette et al. (2000), meaning that the
youngest are the most susceptible to neuronal
damage and death.
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Figure 4. Comparison of DA concentrations over
time in milk and plasma of exposed dams (1.0
mg/kg). Concentrations are in log scale.
*Indicates detectable but nonquantiﬁable DA via a statisti-
cally significant difference in mean from the control as
determined by paired t-test (p = 0.004).
Figure 6. DA concentrations in blood of postnatal day
12 rat pups exposed to either spiked milk or milk from
exposed dams. Error bars represent SDs (n= 6).
aMilk from group 2 dams 4 hr after exposure (1.0 mg/kg)
given directly to pups without spiking. The limit of quantiﬁ-
cation (LOQ) for a milk sample was 0.3 ng/mL.
Figure 5. DA concentrations in urine of exposed
dams (1.0 mg/kg) over time. Error bars represent SDs
(n = 4), and each time point was signiﬁcantly differ-
ent from the control (one-way analysis of variance
with Dunnett’s post-test; p < 0.001). The limit of quan-
tiﬁcation (LOQ) for a sample was 1.0 ng/mL.
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Clearly, neonates are much more suscepti-
ble to systemic administration of DA; however,
DA administered orally to adult rats and mice
is approximately 10-fold less potent (Iverson
et al. 1990). This likely results because, as an
acidic molecule, DA administered orally enters
the bloodstream by rapid absorption through
the gastric mucosa but to a lesser extent though
the intestines. Indeed, Iverson et al. (1990)
reported that most orally administered DA is
eliminated in the feces. Comparison of the
effects of DA administered orally in milk also
indicates that it is about 10-fold less potent
than systemic administration to neonatal rats
(Maucher and Ramsdell, unpublished data).
Our results indicate that the amount of DA a
neonate may be exposed to following a single
feeding (60 ng/kg) from a dam receiving
1.0 mg/kg is about 1/4,000th of an oral dose
causing observable symptoms in neonates.
The ﬁndings presented here demonstrate
that DA was transferable from the plasma to
milk in lactating rats and was retained for
longer periods of time in the milk compared
to plasma. DA-spiked milk was absorbed by
neonates and reached measurable levels in
plasma, although the amount of DA trans-
ferred to the pups from the milk of exposed
dams was well below symptomatic levels.
These results indicate that this experimental
acute DA exposure event in neonatal rats,
although too low to be detectable in milk
from exposed dams, was also insufficient to
cause any acute observable effects in neonates.
Additionally, these results provide a method
to quantify DA in milk, which should be
applicable to human public health concerns
regarding breastfeeding infants, as well as
wildlife exposure assessment.
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